Core Viewpoint - The article highlights the transformative potential of synthetic biology in traditional industries, particularly in agriculture, through a strategic partnership between GELEXIMCO Group, Vietnam National University of Agriculture, and Senrise Biotechnology [1][10]. Group 1: Market Overview - The global synthetic biology market is projected to reach $16 billion by 2024, with an annual growth rate of 27% over the past five years [1]. - Vietnam's agricultural market is substantial, with an estimated total output value of around $50 billion in 2024, showing a rising demand for green agricultural bioproducts [4]. Group 2: Strategic Partnership - The collaboration aims to develop and mass-produce synthetic biological products such as ginsenoside, jasmonate, and astaxanthin, focusing on sustainable agricultural practices [1][4]. - This partnership is expected to enhance cooperation between China and Vietnam in cutting-edge biotechnology, injecting new momentum into the green transformation of agriculture in ASEAN [1][10]. Group 3: Company Profiles - GELEXIMCO Group is a significant player in Vietnam's economy, with annual revenues exceeding 200 trillion VND and total assets reaching 800 trillion VND, aiming to establish a competitive synthetic biology platform [6]. - Vietnam National University of Agriculture is a leading institution in agricultural education and research, providing expertise and local insights for the partnership [7]. - Senrise Biotechnology has developed over 70 patents and utilizes AI algorithms and automated platforms for efficient production, focusing on high-yield chassis cells and precision fermentation [8]. Group 4: Societal Impact - The collaboration is expected to significantly contribute to Vietnam's agricultural green transformation and high-quality development by promoting environmentally friendly agricultural practices [10]. - The project will foster talent development in synthetic biology and modern agriculture, establishing a collaborative innovation platform between academia and industry [10].